Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 17
2018 27
2019 25
2020 40
2021 20
2022 20
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Investigation of autosegmentation techniques on T2-weighted MRI for off-line dose reconstruction in MR-linac workflow for head and neck cancers.
McDonald BA, Cardenas CE, O'Connell N, Ahmed S, Naser MA, Wahid KA, Xu J, Thill D, Zuhour RJ, Mesko S, Augustyn A, Buszek SM, Grant S, Chapman BV, Bagley AF, He R, Mohamed ASR, Christodouleas J, Brock KK, Fuller CD. McDonald BA, et al. Med Phys. 2024 Jan;51(1):278-291. doi: 10.1002/mp.16582. Epub 2023 Jul 20. Med Phys. 2024. PMID: 37475466
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
McDonald BA, Salzillo T, Mulder S, Ahmed S, Dresner A, Preston K, He R, Christodouleas J, Mohamed ASR, Philippens M, van Houdt P, Thorwarth D, Wang J, Shukla Dave A, Boss M, Fuller CD. McDonald BA, et al. Radiother Oncol. 2023 Aug;185:109717. doi: 10.1016/j.radonc.2023.109717. Epub 2023 May 19. Radiother Oncol. 2023. PMID: 37211282 Free PMC article.
Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study.
Joint Head and Neck Radiotherapy-MRI Development Cooperative; Mohamed ASR, Abusaif A, He R, Wahid KA, Salama V, Youssef S, McDonald BA, Naser M, Ding Y, Salzillo TC, AboBakr MA, Wang J, Lai SY, Fuller CD. Joint Head and Neck Radiotherapy-MRI Development Cooperative, et al. Radiother Oncol. 2023 Jun;183:109641. doi: 10.1016/j.radonc.2023.109641. Epub 2023 Mar 27. Radiother Oncol. 2023. PMID: 36990394 Free article.
Practical guidance on modeling choices for the virtual twins method.
Deng C, Wolf JM, Vock DM, Carroll DM, Boatman JA, Hatsukami DK, Leng N, Koopmeiners JS. Deng C, et al. J Biopharm Stat. 2023 Sep 3;33(5):653-676. doi: 10.1080/10543406.2023.2170404. Epub 2023 Mar 6. J Biopharm Stat. 2023. PMID: 36876989 Clinical Trial.
Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation.
McDonald BA, Zachiu C, Christodouleas J, Naser MA, Ruschin M, Sonke JJ, Thorwarth D, Létourneau D, Tyagi N, Tadic T, Yang J, Li XA, Bernchou U, Hyer DE, Snyder JE, Bubula-Rehm E, Fuller CD, Brock KK. McDonald BA, et al. Front Oncol. 2023 Jan 26;12:1086258. doi: 10.3389/fonc.2022.1086258. eCollection 2022. Front Oncol. 2023. PMID: 36776378 Free PMC article. Review.
Quality assurance assessment of intra-acquisition diffusion-weighted and T2-weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy.
Naser MA, Wahid KA, Ahmed S, Salama V, Dede C, Edwards BW, Lin R, McDonald B, Salzillo TC, He R, Ding Y, Abdelaal MA, Thill D, O'Connell N, Willcut V, Christodouleas JP, Lai SY, Fuller CD, Mohamed ASR. Naser MA, et al. Med Phys. 2023 Apr;50(4):2089-2099. doi: 10.1002/mp.16128. Epub 2022 Dec 29. Med Phys. 2023. PMID: 36519973 Free PMC article.
135 results